Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • PZWL - dla zawodowców
  • Obniżka

Treating Pain with Traditional Chinese Medicine

9780912111711
164,00 zł
156,00 zł Zniżka 8,00 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 156,00 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis
This outstanding book examines the causes of pain according to TCM. It is a book tat goes beyond the basic theories of Chinese medicine by applying them to the specific theme of pain. Extremely useful not only for students seeking to understand correct pathomechanism and symptom diagnosis according to Chinese medicine, but as well for practitioners who on a daily basis seek to relieve their patients of common painful discomforts and aliments, this text is certain to be well received by clinicians at many levels of experience.
Szczegóły produktu
Paradigm Press
37183
9780912111711
9780912111711

Opis

Rok wydania
2003
Numer wydania
1
Oprawa
miękka foliowana
  • Section 1:: Reliable determination of the overall effects of treatments

    1) Reliable assessment of the effects of treatment on mortality and major morbidity
    2) The lethal consequences of failing to make full use of all relevant evidence about the effects of medical treatments:: the importance of systematic reviews

    Section 2:: Is the trial relevant to this patient?

    3) Assessment of the external validity of randomised trials
    4) Applying results to treatment decisions in primary care
    5) The older patient
    6) Applying results to treatment decisions in complex clinical situations
    7) External validity of pharmaceutical trials in neuropathic pain
    8) External validity of pharmaceutical trials in asthma and chronic obstructive pulmonary disease

    Section 3:: Is the overall trial result sufficiently relevant this patient?

    9) When should we expect clinically important differences in response to treatment?
    10) Genes and the individual response to treatment
    11) Reliable estimation and interpretation of the effects of treatment in subgroups
    12) Can meta-analysis help target interventions at individuals most likely to benefit?
    13) Use of risk models to predict the likely effects of treatment in individuals
    14) Evaluating the performance of prognostic models
    15) Are n-of-1 trials of any practical value to clinicians or researchers?

    Section 4:: Targeting of treatment in routine practice

    16) Primary prevention of cardiovascular disease:: the absolute risk-based approach
    17) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation
    18) Reperfusion therapies in acute cardiovascular and cerebrovascular syndromes
    19) Choice of agent in treatment of epilepsy
    20) Pharmacogenomic targeting of treatment for cancer
Komentarze (0)

  • Często kupowane razem

    Brak dostępnych produktów